• Gene One Life Science corrected its disclosure: VGXI is negotiating to defer a USD 4 million deposit due Oct. 30, 2026.
• The Conroe plant repurchase agreement automatically terminates if the deposit is not paid by the payment deadline.
• The total repurchase price is USD 39.9 million, with the USD 35.9 million balance due Dec. 15, 2026.
• The repurchase option deadline was extended to Dec. 15, 2026, from Sept. 1, 2026.
• A further correction will follow once an amended agreement deferring the deposit payment is signed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gene One Life Science Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261102800834), on November 02, 2026, and is solely responsible for the information contained therein.